Literature DB >> 7085329

Infantile hypophosphatasia diagnosed at 4 months and surviving at 2 years.

A Albeggiani, F Cataldo.   

Abstract

The authors describe a patient with infantile form of hypophosphatasia who has presented a favourable course and is surviving at the age of 2 years, whereas usually the subjects affected by this disease show an unfavourable prognosis with death within the first 18 months of life. From the age of 5 to 10 months, the patient has been treated with weekly fresh plasma transfusions, with the purpose to supply the deficient enzyme. During treatment a progressive improvement of the clinical and radiological signs was observed. The authors hope that the study of other patients affected by this disease and treated with fresh plasma transfusions, might confirm the effectiveness of this substitutive therapy.

Entities:  

Mesh:

Year:  1982        PMID: 7085329

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  3 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening.

Authors:  B N Chodirker; J A Evans; L E Seargeant; M S Cheang; C R Greenberg
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 3.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.